130 related articles for article (PubMed ID: 10882330)
21. Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Morrissey LH; Scullin DC; Houston GA; Prasthofer EF; Gray JR; Burris HA; Greco FA
Cancer; 2002 May; 94(9):2426-33. PubMed ID: 12033195
[TBL] [Abstract][Full Text] [Related]
22. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma.
Hainsworth JD; Stroup SL; Greco FA
Cancer; 1996 Jun; 77(12):2458-63. PubMed ID: 8640693
[TBL] [Abstract][Full Text] [Related]
23. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials.
Marsland TA; Garfield DH; Khan MM; Look RM; Boehm KA; Asmar L
Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861
[TBL] [Abstract][Full Text] [Related]
24. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of carboplatin-paclitaxel combination chemotherapy in elderly patients with advanced non-small cell lung cancer.
Okamoto I; Moriyama E; Fujii S; Kishi H; Nomura M; Goto E; Kiyofuji C; Imamura F; Mori T; Matsumoto M
Jpn J Clin Oncol; 2005 Apr; 35(4):188-94. PubMed ID: 15845567
[TBL] [Abstract][Full Text] [Related]
27. High-dose therapy with carboplatin and paclitaxel in non-small cell lung cancer.
Socinski MA; Shea TC
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-45-S12-51. PubMed ID: 9331121
[TBL] [Abstract][Full Text] [Related]
28. Treatment of patients with upper gastrointestinal carcinomas.
Ajani JA
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
[TBL] [Abstract][Full Text] [Related]
29. Paclitaxel and carboplatin for advanced breast cancer.
Perez EA; Hartmann LC
Semin Oncol; 1996 Oct; 23(5 Suppl 11):41-5. PubMed ID: 8893899
[TBL] [Abstract][Full Text] [Related]
30. Single-agent vinorelbine in the treatment of non-small cell lung cancer.
Wozniak AJ
Semin Oncol; 1999 Oct; 26(5 Suppl 16):62-6; discussion 71-2. PubMed ID: 10585010
[TBL] [Abstract][Full Text] [Related]
31. The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer.
Bunn PA
Semin Oncol; 1996 Dec; 23(6 Suppl 16):18-25. PubMed ID: 9007116
[TBL] [Abstract][Full Text] [Related]
32. A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung.
Masters GA; Hoffman PC; Drinkard LC; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1998 Feb; 25(1 Suppl 2):8-14. PubMed ID: 9535205
[TBL] [Abstract][Full Text] [Related]
33. Update: vinorelbine (navelbine) in non-small cell lung cancer.
Crawford J
Semin Oncol; 1996 Apr; 23(2 Suppl 5):2-7. PubMed ID: 8610232
[TBL] [Abstract][Full Text] [Related]
34. Vinorelbine (Navelbine) in the adjuvant and neoadjuvant treatment of non-small cell lung cancer.
Viallet J; Ayoub J; Rousseau P; Souhami L; Hohneker J; Shepherd F
Semin Oncol; 1994 Oct; 21(5 Suppl 10):64-71; discussion 71-2. PubMed ID: 7973771
[TBL] [Abstract][Full Text] [Related]
35. The current role and future prospects of paclitaxel in the treatment of small cell lung cancer.
Hainsworth JD; Greco FA
Semin Oncol; 1999 Feb; 26(1 Suppl 2):60-6. PubMed ID: 10190785
[TBL] [Abstract][Full Text] [Related]
36. Carboplatin and paclitaxel in non-small cell lung cancer: the role of amifostine.
Selvaggi G; Belani CP
Semin Oncol; 1999 Apr; 26(2 Suppl 7):51-60. PubMed ID: 10348261
[TBL] [Abstract][Full Text] [Related]
37. Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer.
Fossella FV; Lee JS; Berille J; Hong WK
Semin Oncol; 1995 Apr; 22(2 Suppl 4):22-9. PubMed ID: 7740327
[TBL] [Abstract][Full Text] [Related]
38. New options in the treatment of non-small cell lung cancer.
Fossella F; Rigas JR; Belani CP
Anticancer Drugs; 1999 Nov; 10 Suppl 1():S25-8. PubMed ID: 10630365
[TBL] [Abstract][Full Text] [Related]
39. Preoperative paclitaxel plus carboplatin for patients with intermediate-risk non-small cell lung cancer.
Ruckdeschel JC
Semin Oncol; 1996 Dec; 23(6 Suppl 16):62-7. PubMed ID: 9007125
[TBL] [Abstract][Full Text] [Related]
40. Ifosfamide and paclitaxel combinations for the treatment of advanced non-small cell lung cancer.
Shepherd FA; Eisenhauer E
Semin Oncol; 1998 Feb; 25(1 Suppl 2):2-7. PubMed ID: 9535204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
